Managing an Elevated PSA: What Most Men Are Never Told

An elevated PSA can feel like a trap.

One blood test turns into fear, pressure, and a fast-moving conveyor belt toward biopsy, surgery, or radiation. Many men are told there is no alternative. Act now or regret it later.

According to Dr. Stephen Petteruti, that framing is wrong—and dangerous.

In this podcast, Dr. Petteruti breaks down why PSA has been misunderstood for decades, how prostate cancer has been historically misclassified, and why aggressive early intervention often causes harm without improving survival.

This conversation has resonated with men around the world. The video has been viewed 157,998 times since publication, with over 25,000 hours of watch time, reflecting how deeply this message connects with those navigating PSA decisions.

The hard truth most men never hear.

Prostate cancer has a five-year survival rate near 99 percent—even when no treatment is done. That reality alone should change how decisions are made. Yet PSA numbers still drive panic, even though PSA is not a diagnostic test for cancer and never has been.

Dr. Petteruti explains how PSA naturally rises with age, prostate size, and inflammation—and why using a single number to justify invasive procedures makes no biological sense.

Why biopsies often create more problems

A prostate biopsy is not a simple test. It involves multiple core samples taken blindly from a sensitive gland. Dr. Petteruti discusses:

• Why biopsies do not predict future cancer behavior
• How negative biopsies still leave men stuck in fear
• Evidence from other cancers showing needle-track spread
• Why repeated biopsies during “active surveillance” defy logic

Once a biopsy labels cells as cancer, most men feel psychologically cornered into treatment—even when outcomes do not improve.

Surgery and radiation do not deliver the promise men are sold

One of the most sobering discussions in the podcast centers on long-term outcome studies. When men with prostate cancer were followed for 20 years, those who had surgery, radiation, or no treatment had the same death rates.

The difference was quality of life.

Dr. Petteruti explains the irreversible consequences many men live with after treatment—urinary leakage, erectile dysfunction, bowel damage, cognitive decline—and why these risks are often minimized during rushed consultations.

A different question changes everything
Instead of asking, “How do we remove the prostate?” Dr. Petteruti asks a more important question:

What keeps cancer dormant—and what causes it to spread?

The podcast explores how immune function, inflammation, toxin burden, metabolic health, and cardiovascular disease play a larger role in outcomes than prostate procedures ever have.

Men do not usually die from prostate cancer. They die with it—most often from heart disease.

What a smarter path looks like

Without giving away the full protocol, Dr. Petteruti outlines a rational alternative approach that focuses on:

• Monitoring with prostate MRI instead of routine biopsy
• Supporting immune surveillance
• Reducing carcinogenic toxin exposure
• Addressing cardiovascular and metabolic risk
   
• Preserving vitality, testosterone, and quality of life

This is not about ignoring cancer. It is about avoiding harm while doing something meaningful.

Why this conversation matters now

Prostate cancer care has become a multi-billion-dollar industry driven by momentum, liability concerns, and outdated assumptions. Changing course requires education, courage, and informed consent.

This podcast is not comfortable—but it is necessary.

If you or someone you love has an elevated PSA, this conversation could change how you think about prostate cancer forever.

Watch the full podcast here:
Managing an Elevated PSA: Avoiding Unnecessary Prostate Biopsies